Medtronic reports growth is slowing in defibrillator sales

Article Abstract:

Medtronic Inc. posted a sharp drop in cardiac defibrillator sales for the fourth-quarter ending April 27, 2001. The company also posted a 10% rise in profits for the period.

Sales, profits & dividends, Electromedical and Electrotherapeutic Apparatus Manufacturing, Surgical Appliance and Supplies Manufacturing, Surgical appliances and supplies, Electromedical equipment, Surgical Appliances & Supplies, Defibrillator Monitors & Recorders, Finance, Defibrillators, Surgical equipment and supplies industry, Medtronic Inc., MDT

---

Boston Scientific vies for Guidant

Article Abstract:

Boston Scientific Corp. of the United States has bid $25 billion for Guidant Corp. also of the United States, threatening to cause a bidding war with Johnson & Johnson who previously had a lower-price acquisition deal with Guidant Corp. The medical equipment manufacturer Boston Scientific Corp. has a market valuation of $22.4 billion.

---

Boston Scientific leaps past J&J with $27 billion bid for Guidant

Article Abstract:

The takeover battle for Guidant Corp. of the United States is heating up with Boston Scientific Corp. also of the United States, offering $27 billion. The medical equipment giant offered $80 per share or $9 per share ($3 billion) greater than Johnson & Johnson also of the United States.

Similar abstracts:

• Abstracts: Northwest, Continental finalize plans for a $450 million share buyback. American Airlines Makes Overtures To Northwest
• Abstracts: EchoStar is in talks with potential allies in a bid for Hughes. News Corp. effort to acquire Hughes is getting tougher
• Abstracts: RIM to pay NTP $612.5 million to settle BlackBerry patent suit. 360networks seeks court protection from creditors
• Abstracts: Nissan to rev up its liquidity to win higher credit ratings. Suzuki's group net tumbled as sales rose for the year
• Abstracts: EU, U.S. regulators pobe online deal; Cendant's acquisition of Gallileo draws scrutiny. Cendant buys eBookers in $404 million deal

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.